Bond.az White LogoBond.az Black Logo

CVS Group Launches £50M Share Buyback Programme

CVS Group launches £50 million share buyback programme to return capital to shareholders and reduce share capital.

Isabella Martinez
ByIsabella Martinez- Senior Editor
|
0

Bond.az reports: CVS Group plc (LSE:CVSG) announced the start of a share buyback programme to purchase up to £50 million of its ordinary shares.

The veterinary services provider aims to return surplus capital to shareholders and reduce share capital. All repurchased shares will be cancelled.

CVS appointed Peel Hunt LLP and Joh. Berenberg, Gossler & Co. KG, London Branch as brokers, who will act as riskless principals and trade independently.

Purchases will occur on the London Stock Exchange and other venues, under shareholder authority granted on November 18, 2025, allowing up to 6,040,012 shares.

The buyback complies with FCA Listing Rules Chapter 9 and EU regulations. CVS will announce purchases within seven market sessions.

The programme is expected to conclude by November 24, 2026.

More News
Today / 07:04
|
236

Enhertu Gets EU Panel Backing for HER2+ Tumors

Enhertu receives EU panel backing for HER2-positive solid tumors. If approved, it would be the first tumor agnostic HER2 therapy in the EU.

0
Today / 07:02
|
716

Arrow Exploration: Production from IC-1 Well

Arrow Exploration reports production from IC-1 well in Colombia. Initial rates reach 735 bopd gross.

0
Today / 06:33
|
721

Vietnam GDP grows 7.83% in Q1 2026

Vietnam's Q1 2026 GDP growth hits 7.83%, with exports surging 19.7%. Read more on Bond.az.

0
Today / 06:32
|
250

Cora Gold Begins FEED Work at Mali Project

Cora Gold starts FEED at Sanankoro Gold Project in Mali. FEED completion expected in H2 2026. Latest mining news.

0
Today / 06:30
|
231

Poolbeg Pharma Gets FDA Feedback on POLB 001

Poolbeg Pharma receives FDA feedback on POLB 001 for cancer immunotherapy-induced Cytokine Release Syndrome.

0
Today / 05:33
|
998

Jyske Bank buys back 66,770 shares in week 21

Jyske Bank buys back 66,770 shares in week 21 at an average price of DKK 901.28 per share, totaling DKK 60.28 million.

0
Today / 03:31
|
967

Hansa Biopharma trial results at ATC in June

Hansa Biopharma's Phase 3 ConfIdeS trial results for kidney transplantation will be presented at ATC 2026. 12-month data including eGFR and safety.

0
Yesterday / 22:31
|
768

FinVolution Announces $150M Share Buyback

FinVolution Group announces $150M share buyback program. Shares near 52-week low with 6.4% dividend yield.

0
Yesterday / 17:33
|
459

Aliko Scientific, BioBrasil to Manufacture FISH Probes in Brazil

Aliko Scientific partners with BioBrasil to manufacture FISH probes in Brazil via a joint venture. Revenue grew 81%.

0
Yesterday / 13:04
|
590

HyOrc Sells Gasification Unit to Indian Municipality

HyOrc sells a 3-ton/day gasification unit to Assam, India. Stock up 458% in a year. OTCQB: HYOR.

0
Yesterday / 12:34
|
346

Taseko Mines Proposes Name Change to Trekor Metals

Taseko Mines proposes name change to Trekor Metals. Shareholders will vote on June 24, 2026. The change reflects North American expansion.

0
Yesterday / 11:01
|
767

Eisai's new 3-year plan seen as conservative

Eisai's new three-year plan targets ¥1 trillion sales and ¥90 billion profit. Analysts view the plan as conservative.

0
...
CVS Group Launches £50M Share Buyback Programme | Bond.az